Influence of lipid-lowering drugs on homocysteine level [2];Influence du traitement hypolipémiant sur l'homocystéinémie

Revue de Medecine Interne

Volumn 23, Issue 8, 2002, Pages 735-736

  Roblin, X ^a   Boudemaghe, T ^a   Paris, F ^a   Pellissier, L ^a   Le Gall, S ^a  

^a CENTRE HOSPITALIER   (France)

Author keywords

Fibrate; Homocysteine; Statine

Indexed keywords

ANTILIPEMIC AGENT; AZATHIOPRINE; FIBRIC ACID DERIVATIVE; HOMOCYSTEINE; LEVODOPA; METHOTREXATE; STATINE DERIVATIVE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; BODY MASS; DRUG EFFECT; FEMALE; FRANCE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ANTILIPEMIC AGENTS; CHILD; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 0036671862     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Lipid-lowering drugs and homocysteine
2. Serum homocysteine increases after therapy with fenofibrate or bezafibrate
3. Effects of fenofibrate and gemfibrozil on plasma homocysteine